Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Items
New Content
Mount Sinai Awarded $4.5M BD2 Grant to Advance Research on the Biology of Bipolar Disorder
The Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar ...
Chronic traumatic encephalopathy (CTE) is more common in people who experience extensive repetitive head impacts, and infrequent among individuals with isolated brain injuries or less extensive impacts, researchers from the Brain Injury ...
Consensus Defines Postpartum Psychosis as Distinct Clinical Entity
An international panel of leading experts on women’s mental health is recommending that postpartum psychosis be recognized as a distinct category of mental illness and classified accordingly within standardized medical coding systems.
Mount Sinai’s MASLD/MASH Center of Excellence Focuses on Liver Disease Science and Treatment
Raising public awareness of MASH (metabolic dysfunction-associated steatohepatitis) and its precursor condition, MASLD (metabolic dysfunction-associated steatotic liver disease), is a top priority for Mount Sinai's MASLD/MASH Center of ...
ARPA-H Funds Mount Sinai Research to Inhibit Cellular Mechanisms of Viral Spread
Researchers at the Icahn School of Medicine at Mount Sinai have received up to $11.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to identify and block the cellular entry points viruses exploit to infect, replicate, and spread.
Improving MASH Treatment With Medically Tailored Meals
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators are launching an innovative new program to deliver medically tailored meals to people with steatotic liver disease. The goal is to make behavioral lifestyle changes more achievable.
Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that do not involve biopsies, a team ...
Breakthrough Study Could Transform Treatment for Patients With Severe Limb Injuries
In the study, published on the front page of Clinical Orthopaedics and Related Research in June 2025, Mount Sinai Health System’s Michael R. Hausman, MD; Paul J. Cagle Jr., MD; and Christoph A. Schroen, a doctoral student, identify a new ...
Providing Comprehensive Care for Patients With Microtia and Atresia
Patients with microtia and atresia, along with their families, often face difficult decisions as they navigate hearing loss and social stigma. At the Ear Institute at New York Eye and Ear Infirmary of Mount Sinai, they receive personalized ...
Mount Sinai Studies Reveal Molecular Gaps in Living vs. Postmortem Brain
Two new research papers from the landmark Living Brain Project at Mount Sinai present what is, by several metrics, the largest investigation ever performed of the biology of the living human brain
Augmenting Neurostimulation Treatments With Motion Capture Technology
The Charles Lazarus Children’s Abilities Center at Mount Sinai is one of only two institutions in New York City that will have a marker-based, multi-camera motion capture facility. This facility will enable the Center to be the first nationwide ...
Sleep-Monitoring Devices Can Help Detect Neurological Issues
A Mount Sinai researcher has demonstrated that commonly used wrist actigraphy devices can accurately detect REM sleep behavior disorder (RBD). Because at least half of patients with RBD go on to develop a neurological disease such as Parkinson’s ...
Specialty Reports September 2025
Mount Sinai Health System is pleased to present these reports covering our groundbreaking research and compassionate, equitable, and safe patient care.
New IL-23 Inhibitors Expand Treatment Options for Crohn’s Disease
The U.S. Food and Drug Administration has approved two new medications for Crohn’s disease, following the results of successful multisite clinical trials conducted in part at the Icahn School of Medicine at Mount Sinai. The therapies, ...
Same-Day Discharge of Colorectal Surgery Patients Is Gradually Taking Shape at Mount Sinai
A rigorous protocol that Mount Sinai colorectal surgeons have methodically developed is showing highly encouraging results that generally support the feasibility and safety of same-day colorectal surgery discharge in a carefully controlled environment.
Probing the Power of Hepatocyte Regeneration to Treat Chronic Liver Disease
While scientists have made significant strides in detailing the mechanisms of regeneration in healthy livers, less understood is what happens in an ailing liver. In chronic diseases such as MASH, hepatocytes are less able to regenerate ...